2 Top Biotech Stocks to Buy in October

Since the consumer price index (an inflation indicator) rose 5.3% year over year in August, it's as important as ever to buy dividend stocks that can raise their dividend ahead of inflation to gain purchasing power. Here are two biotech stocks that not only can stay ahead of inflation through strong dividend increases but that are fairly priced and offer enticing 3% yields. Bristol Myers Squibb (NYSE: BMY) is the first biotech stock that investors should consider purchasing in October.